Targeting gut microbiota in obesity: effects of prebiotics and probiotics (Q37913992)

25 August 2017

1 reference

title

Targeting gut microbiota in obesity: effects of prebiotics and probiotics (English)

1 reference

25 August 2017

0 references

0 references

3

1 reference

25 August 2017

4

1 reference

25 August 2017

Audrey M Neyrinck

2

0 references

Nathalie M. Delzenne

object named as

Nathalie M Delzenne

series ordinal

1

0 references

publication date

9 August 2011

1 reference

Nature Reviews Endocrinology

25 August 2017

1 reference

25 August 2017

7

1 reference

25 August 2017

639-646

1 reference

25 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2011.126

25 August 2017

0 references

cites work

Intestinal microbiota during infancy and its implications for obesity

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

A human gut microbial gene catalogue established by metagenomic sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Viruses in the faecal microbiota of monozygotic twins and their mothers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

A core gut microbiome in obese and lean twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Obesity alters gut microbial ecology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

An obesity-associated gut microbiome with increased capacity for energy harvest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Microbial ecology: human gut microbes associated with obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Human colonic microbiota associated with diet, obesity and weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Microbiota and SCFA in lean and overweight healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Obesity and the human microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Effects of the gut microbiota on obesity and glucose homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Genotype Is a Stronger Determinant than Sex of the Mouse Gut Microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

High-fat diet determines the composition of the murine gut microbiome independently of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Absence of intestinal microbiota does not protect mice from diet-induced obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Prebiotic effects: metabolic and health benefits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Acquisition, evolution and maintenance of the normal gut microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Mucin-bacterial interactions in the human oral cavity and digestive tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

The gut microbiota as an environmental factor that regulates fat storage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Colonization-induced host-gut microbial metabolic interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

The role of the gut microbiota in energy metabolism and metabolic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Metabolic endotoxemia initiates obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Energy intake is associated with endotoxemia in apparently healthy men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Chylomicrons promote intestinal absorption of lipopolysaccharides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

The endocannabinoid system links gut microbiota to adipogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

The endocannabinoid system and its relevance for nutrition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Acute-phase serum amyloid A as a marker of insulin resistance in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Early differences in fecal microbiota composition in children may predict overweight.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Molecular characterisation of the faecal microbiota in patients with type II diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Oligofructose promotes satiety in healthy human: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Probiotics - little evidence for a link to obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

No causal link between obesity and probiotics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Human microbiome: take-home lesson on growth promoters?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Arabinoxylan fibre improves metabolic control in people with Type II diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.126

Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21826100

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRENDO.2011.126

1 reference

PubMed ID

21826100

Dimensions Publication ID

25 August 2017

0 references

1 reference

PubMed ID

21826100